May. 5 at 4:44 PM
$ABCL AbCellera Biologics Inc. (ABCL) priced its initial public offering (IPO) at
$20.00 per share on December 10, 2020. The company, which provides an AI-powered antibody drug discovery platform, listed on the Nasdaq Global Select Market on December 11, 2020. The IPO was upsized, with 24,150,000 common shares sold, raising roughly
$483 million. [1, 2, 3, 4]
Key IPO Details
IPO Price:
$20.00 per share
Opening Price:
$61.00 per share
Ticker Symbol: ABCL
IPO Date: December 11, 2020 [1, 2, 3, 4]
The IPO was initially expected to price between
$14 and
$17, but was raised to
$17 to
$18 before settling at
$20. On its first day of trading, the stock experienced a significant debut, more than tripling to open at
$61 per share
